Clinical Trials
2 trialsNCT03150056 2022-08-10
Dose Escalation and Dose Expansion Study of GSK525762 in Combination With Androgen Deprivation Therapy in Participants With Castrate-resistant Prostate Cancer
GlaxoSmithKline
Phase 1 Terminated
NCT03702036 2020-04-13
Compassionate Use Individual Request Program for GSK525762 in NUT Midline Carcinoma
GlaxoSmithKline
No longer available